InterCure Ltd. (INCR)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $49.17M
Last updated: Nov 17, 2026 at 4:10 PM ET
InterCure Ltd. (INCR) Stock Chart
InterCure (INCR) has a latest price of $3.61 on Nov 17, 2026, 52.2% below its 52-week high of $7.55. Its price fell 47.3% over the past 12 months. The month-end price fell 98.3% over the 10 years through Oct 2026, a compound annual decline of 33.3%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $293.50 in Aug 2017 and its lowest $3.75 in Mar 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart INCR with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for INCR.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 22.4%, and over 6 months it fell 15.1%. The month-end price fell 21.4% over the 3 years through Oct 2026, a compound annual decline of 7.7%.
| Period | Change |
|---|---|
| 1 month | -19.1% |
| 3 months | -22.4% |
| 6 months | -15.1% |
| 12 months | -47.3% |
| 12 months, with dividends | -47.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -21.4% | -7.7% |
| 5 years | -88.3% | -34.9% |
| 10 years | -98.3% | -33.3% |
Price by Year
Its best calendar year was 2024, when the price rose 23.3%, and its weakest was 2023, when it fell 60.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.97 | -12.7% |
| 2025 | $4.55 | -42.8% |
| 2024 | $7.95 | +23.3% |
| 2023 | $6.45 | -60.9% |
| 2022 | $16.50 | -49.1% |
| 2017 | $218.00 | -17.1% |
Trading Range
The price is 22.6% below its 50-day average of $4.66 and 20.8% below its 200-day average of $4.56.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.61 | |
| 52-week high | $7.55 | -52.2% |
| 52-week low | $3.12 | +15.7% |
| 50-day average | $4.66 | -22.6% |
| 200-day average | $4.56 | -20.8% |
Price Risk
Over 3 years, its largest fall from a peak was 81.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.06 |
| Largest fall, 1 year | -54.6% |
| Largest fall, 3 years | -81.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About INCR
What is INCR's 1-year price change?
InterCure's price fell 47.3% over the past 12 months. With dividends included, the 12-month total return was -47.3%.
What is INCR's 5-year price change?
InterCure's month-end price fell 88.3% over the 5 years through Oct 2026, a compound annual decline of 34.9%. These figures leave out dividends.
What is INCR's 52-week high and low?
InterCure's 52-week high is $7.55 and its 52-week low is $3.12. Its latest price of $3.61 on Nov 17, 2026 is 52.2% below the high.
What is INCR's beta?
InterCure's 1-year beta against the S&P 500 is 1.06, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 54.6%.
Is the INCR chart free?
Yes. Advanced Charting for INCR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
INCR pages: Overview, Charting, Financials